Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment

INTRODUCTION: We prospectively tested in a phase II study high-dose aracytin and idarubicin plus amifostine as induction regimen in 149 patients with acute myeloid leukaemia (AML) aged ≥ 60 years, evaluated by a simplified multidimensional geriatric assessment (MGA). METHODS: Ninety-one fully or par...

Descripción completa

Detalles Bibliográficos
Autores principales: Capelli, Debora, Saraceni, Francesco, Fiorentini, Alessandro, Chiarucci, Martina, Menotti, Diego, Poloni, Antonella, Discepoli, Giancarlo, Leoni, Pietro, Olivieri, Attilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467471/
https://www.ncbi.nlm.nih.gov/pubmed/32297279
http://dx.doi.org/10.1007/s12325-020-01310-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467471/
https://www.ncbi.nlm.nih.gov/pubmed/32297279
http://dx.doi.org/10.1007/s12325-020-01310-4

Ejemplares similares